Plasma brain natriuretic peptide in takotsubo cardiomyopathy

QJM: An International Journal of Medicine

Volumn 97, Issue 9, 2004, Pages 599-607

  Akashi, Y Johny ^a,b   Musha, H ^a   Nakazawa, K ^b   Miyake, F ^b  

^a ST MARIANNA UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE; ARTICLE; BLOOD SAMPLING; CARDIOMYOPATHY; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; DIASTOLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART INDEX; HEART VENTRICLE CONTRACTION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; SYSTOLE;

EID: 4544339491     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch094     Document Type: Article

References (28)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-9.
2. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol 1988; 12:600-5.
3. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasm: a review of 5 cases. J Cardiol 1991; 21:203-14 (in Japanese).
4. Salathe M, Weiss P, Ritz R. Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J 1992; 68:527-8.
5. Iga K, Himura Y, Izumi C, Miyamoto T, Kijima K, Gen H, Konishi T. Reversible left ventricular dysfunction associated with Guillain-Barré syndrome: An expression of catecholamine cardiotoxicity? Jpn Circ J 1995; 59:236-40.
6. Kawai S, Suzuki H, Yamaguchi H, Tanaka K, Sawada H, Aizawa T, Watanabe M, Tamura T, Umawatari K, Kawata M, Nakamura T, Yamanaka O, Okada R, Kawada M. Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy) -reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J 2000; 64:156-9.
7. Owa M, Aizawa K, Urasawa N, Ichinose H, Yamamoto K, Karasawa K, Kagoshima M, Koyama J, Ikeda S. Emotional stress-induced 'ampulla cardiomyopathy': discrepancy between the metabolic and sympathetic innervation imaging performed during the recovery course. Jpn Circ J 2001; 65:349-52.
8. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol 2001; 38:11-18.
9. Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: a possible animal model of 'tako-tsubo' cardiomyopathy. Circ J 2002; 66:712-13.
10. Kurisu S. Transient left ventricular hypocontraction induced by emotional stress with immobilization: an animal model of tako-tsubo cardiomyopathy in humans? Circ J 2002; 66:985-6.
11. Akashi YJ, Sakakibara M, Miyake F. Reversible left ventricular dysfunction: 'takotsubo' cardiomyopathy associated with pneumothorax. Heart 2002; 87:E1.
12. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Sasaka K. Reversible left ventricular dysfunction: 'takotsubo' cardiomyopathy related to catecholamine cardiotoxicity. J Electrocardiol 2002; 35:351-6.
13. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003; 41:737-42.
14. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Umemura T, Nakamura S, Yoshida M, Sato H. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol 2003; 41:743-8.
15. Akashi YJ, Nakazawa K, Kida K, Ryu S, Takagi A, Kishi R, Kunishima T, Sakakibara M, Miyake F. Reversible ventricular dysfunction (takotsubo cardiomyopathy) following polymorphic ventricular tachycardia. Can. J. Cardiol. 2003; 19:449-51.
16. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of takotsubo cardiomyopathy. Q J Med 2003; 96:563-73.
17. 123I-MIBG myocardial scintigraphy in patients with takotsubo cardiomyopathy. J Nucl Med 2004; 45:1121-7.
18. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90:195-203.
19. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28:988-94.
20. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilse DWT, Sndsfjord JA, Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93:1963-9.
21. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsmura T, Mukoyama M, Nakano K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88:82-91.
22. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide: a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135:825-32.
23. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenuation of compensation of endogeneous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96:509-16.
24. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, Ohnishi M, Sawaki M, Fujii M, Hiroe H, Sugimoto Y, Kinoshita M. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with symptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 1999; 20:1799-807.
25. Chapman CB, Baker O, Raynolds J, Bonte FJ. Use of biplane cineangiography for measurement of ventricular volume. Circulation 1958; 18:1105-17.
26. Ueyama T, Yoshida K, Senba E. Emotional stress induces immediate-early gene expression in rat heart via activation of α- and β-adrenoceptors. Am J Physiol 1999; 277:H1553-61.
27. Ueyama T, Senba E, Kasamatsu K, Hano T, Yamamoto K, Nishio I, Tsuruo Y, Yoshida K. Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J Cardiovasc Pharmacol 2003; 41 (Suppl. 1):S115-18.
28. Murphree SS, Saffits JE. Quantiive autoradiographic delineation of the distribution of beta-adrenergic receptors in canine and feline left ventricular myocardium. Circ Res 1987; 60:568-79.